MedPath

analysis of flow in kidney blood vessels to predict kidney injury earlier, in adult living donor liver transplant patients

Completed
Conditions
Liver disease, unspecified, (2) ICD-10 Condition: O||Medical and Surgical,
Registration Number
CTRI/2023/05/052918
Lead Sponsor
Dr Rela Institute and Medical Centre
Brief Summary

This is a prospective observational study to find out the role of measuring renal resistive index in predicting acute kidney injuryin patients undergoing living donor liver transplantation surgeries. The renal resistive index (RRI) is a non-invasive ultrasonographic Doppler tool which measures blood flow velocity in intra-parenchymal renal arteries. Normal values are reported between 0.60 to 0.70 with the difference between both kidneys being mostly less than 5%.              Tacrolimus is one of the drugs used in immunosuppressive therapy of organ transplant recipients and its potency has been proven in treating early graft dysfunction, graft loss, acute rejection, new onset diabetes after transplant and hypertension.

Study population  includes those who are above 18years of age. Total sample size is 100. These patients RRI is measured pre operatively and follow up til POD 05 along with tacrolimus trough level, renal function biochemical parameters, eGFR, urine output etc.



Our secondary objective is to find the association with tacrolimus trough levels,eGFR along with RRI in predicting AKI.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

1.To assess whether RRI could predict acute kidney injury in the post-operative period in patients undergoing living donor liver transplantation.

Exclusion Criteria
  • 1.To find the correlation between trough tacrolimus levels and RRI.
  • 2.To find the association between urea, creatinine, estimated glomerular filtration rate and RRI.
  • 3.To assess whether RRI could predict recovery from acute kidney injury.
  • 4.To assess the changes in RRI and its association with patient outcomes – sepsis, mechanical ventilation, wound infection, length of ICU stay and hospital stay.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
increase in RRI will preceede the changes in creatinine and will help to predict AKI earlyPre operative day, POST OPERATIVE 01 TO POST OPERATIVE 05
Secondary Outcome Measures
NameTimeMethod
Association between RRI & Tacrolimus trough levelsAssociation of RRI with blood Urea,s.creat, eGFR

Trial Locations

Locations (1)

Dr Rela Institute and Medical Centre

🇮🇳

Chennai, TAMIL NADU, India

Dr Rela Institute and Medical Centre
🇮🇳Chennai, TAMIL NADU, India
Dr Kavinandan G
Principal investigator
9902770982
kavinandangmk@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.